The Evolution of Global Paediatric Palliative Care: Addressing the 10.6 Million Children in Need
For decades, the clinical perception of palliative care has been inextricably linked with terminal illness and the final days of life. However, a groundbreaking study published in The Lancet Child & Adolescent Health (2026) challenges this paradigm, revealing a massive and evolving burden of Serious Health-related Suffering (SHS) among the world’s youth. The data, spanning from 1990 to 2023, underscores a critical reality: 10.6 million children aged 0-19 years are currently in need of palliative care, and the vast majority are not dying, but living with profound, chronic suffering.
The Scale of Serious Health-related Suffering (SHS)
The study defines SHS as suffering associated with any illness or injury that cannot be relieved without professional medical intervention. By 2023, the global count reached 10.6 million children, a figure that has remained tragically stable over three decades despite advancements in global medicine. Perhaps most striking is the geographic distribution of this burden: 96% of these children reside in low-income and middle-income countries (LMICs). In these regions, access to specialized palliative services, essential pain medications like morphine, and multidisciplinary support teams remains a rare luxury rather than a standard of care.
Methodology: A Tool for Policy Transformation
To reach these conclusions, researchers utilized an updated SHS methodology originally developed by The Lancet Commission on Global Access to Palliative Care and Pain Relief. The team, supported by a panel of international paediatric experts, analyzed data from the Global Burden of Disease Study 2023. They categorized the burden into two distinct groups: decedents (those who died within the past year) and non-decedents (those surviving with persistent, progressive, or chronic suffering). This distinction is vital for health system planning, as the care requirements for a child living for years with a metabolic disorder differ significantly from those in the terminal phase of cancer.
The Decisive Shift: From Dying to Living with Suffering
One of the most significant findings of this 30-year analysis is the structural shift in the nature of paediatric suffering. In 1990, non-decedents—survivors experiencing SHS—accounted for 59% of the total burden. By 2023, this proportion surged to 81%. This shift suggests that while global health initiatives have successfully reduced child mortality for many conditions, they have not yet succeeded in reducing the associated morbidity. Children are surviving longer with complex conditions, yet they are doing so without the necessary symptom management and psychological support. This “survival paradox” places an unprecedented demand on healthcare systems to provide longitudinal palliative care that integrates with curative or life-prolonging treatments.
Key Drivers of the SHS Burden
In 2023, the health conditions contributing most significantly to the global SHS burden in children were identified as follows:
1. Endocrine, metabolic, blood, and immune disorders: These accounted for a staggering 51% of the total SHS burden. This category includes conditions like sickle cell disease and primary immunodeficiencies, which require lifelong pain management and specialized care.
2. Premature birth and birth trauma: Representing 18% of the burden, these conditions highlight the long-term neurodevelopmental and physical challenges faced by neonatal survivors in resource-limited settings.
3. Injury, poisoning, and external causes: At 7%, this category reminds clinicians that acute trauma often leaves a long tail of chronic physical and psychological suffering.
The LMIC Disparity: A Call for Health Equity
The fact that 9.6 out of 10 children needing palliative care live in LMICs represents one of the most profound inequities in modern medicine. In high-income countries, paediatric palliative care (PPC) is increasingly integrated into tertiary centers. In contrast, many LMICs lack the basic infrastructure for pain relief. The study emphasizes that the global community must move beyond a “one-size-fits-all” approach and develop localized, adequately funded policies that ensure essential medicines—particularly oral morphine—are available and that healthcare workers are trained in the nuances of paediatric-specific care.
Clinical and Policy Implications
For clinicians and policymakers, the implications are clear. First, palliative care must be recognized as a component of Universal Health Coverage (UHC). Second, there is an urgent need to pivot service models to support non-decedents. This involves moving care into the community and primary care levels to support families over many years, not just weeks. Finally, the high prevalence of metabolic and blood disorders as drivers of SHS suggests that specialized palliative interventions should be integrated early into the management of these chronic conditions.
Conclusion
The findings of Downing et al. serve as a sobering reminder that the success of modern medicine is not measured solely by the prevention of death, but by the quality of life afforded to survivors. As the burden of paediatric suffering continues to shift toward those living with chronic disease, global health systems must evolve. Reducing the avoidable burden of SHS among the world’s 10.6 million affected children is not just a clinical goal—it is a moral imperative that requires immediate, funded, and evidence-based action.
Funding and Acknowledgments
This research was funded by the University of Miami. The authors declare no competing interests. The study provides a critical measurement tool for international organizations to monitor progress toward the UN Sustainable Development Goals related to health and wellbeing.
References
Downing J, Knaul FM, Kwete XJ, et al. The global need for paediatric palliative care: the evolution of serious health-related suffering in children aged 0-19 years from 1990 to 2023. Lancet Child Adolesc Health. 2026;10(3):167-178. doi:10.1016/S2352-4642(25)00338-4.